Q32 Bio (QTTB) Interest & Investment Income (2017 - 2023)
Q32 Bio's quarterly Interest & Investment Income came in at $1.2 million in Q4 2023, down 18.97% year-on-year from $1.5 million in Q4 2022, and down 17.15% quarter-over-quarter from $1.4 million in Q3 2023.
Q32 Bio has reported Interest & Investment Income for 7 years, with the latest figure at $1.2 million in Q4 2023.
- For the quarter ending Q4 2023, Interest & Investment Income fell 18.97% year-over-year to $1.2 million; the trailing twelve-month figure through Dec 2023 stood at $5.6 million (up 72.82% YoY), and the FY2023 full-year result was $5.6 million, up 72.82% from the prior year.
- Interest & Investment Income for Q4 2023 stood at $1.2 million, down from $1.4 million in the prior quarter.
- The five-year high for Interest & Investment Income was $1.7 million in Q2 2019, with the low at $11000.0 in Q4 2020.
- Average Interest & Investment Income over 5 years is $829700.0, with a median of $1.2 million recorded in 2020.
- Year-over-year, Interest & Investment Income plunged 99.21% in 2020 and soared 4490.62% in 2023.
- Tracing QTTB's Interest & Investment Income over 5 years: stood at $1.4 million in 2019, then sank by 99.21% to $11000.0 in 2020, then jumped by 281.82% to $42000.0 in 2021, then soared by 3364.29% to $1.5 million in 2022, then retreated by 18.97% to $1.2 million in 2023.
- The last three Interest & Investment Income figures came in at $1.2 million (Q4 2023), $1.4 million (Q3 2023), and $1.5 million (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.18 Mn |
| Sep 30, 2023 | 1.42 Mn |
| Jun 30, 2023 | 1.51 Mn |
| Mar 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | 1.46 Mn |
| Sep 30, 2022 | 1.27 Mn |
| Jun 30, 2022 | 474,000.00 |
| Mar 31, 2022 | 32,000.00 |
| Dec 31, 2021 | 42,000.00 |
| Sep 30, 2021 | 53,000.00 |
| Jun 30, 2021 | 52,000.00 |
| Mar 31, 2021 | 38,000.00 |
| Dec 31, 2020 | 11,000.00 |
| Sep 30, 2020 | 41,000.00 |
| Jun 30, 2020 | 357,000.00 |
| Mar 31, 2020 | 1.16 Mn |
| Dec 31, 2019 | 1.39 Mn |
| Sep 30, 2019 | 1.66 Mn |
| Jun 30, 2019 | 1.70 Mn |
| Mar 31, 2019 | 1.27 Mn |
| Dec 31, 2018 | 1.39 Mn |
| Sep 30, 2018 | 1.49 Mn |
| Jun 30, 2018 | 996,000.00 |
| Mar 31, 2018 | 479,000.00 |
| Dec 31, 2017 | 356,306.00 |
| Sep 30, 2017 | 137,202.00 |
| Jun 30, 2017 | 35,766.00 |
| Mar 31, 2017 | 12,725.00 |